Cargando…
Convalescent or standard plasma versus standard of care in the treatment of COVID-19 patients with respiratory impairment: short and long-term effects. A three-arm randomized controlled clinical trial
BACKGROUND: The efficacy of early treatment with convalescent plasma in patients with COVID-19 is debated. Nothing is known about the potential effect of other plasma components other than anti-SARS-CoV-2 antibodies. METHODS: To determine whether convalescent or standard plasma would improve outcome...
Ejemplares similares
-
First Human Usutu Virus Reported in Asti (Piedmont, Italy, August 2022) and Early Follow-Up
por: Lupia, Tommaso, et al.
Publicado: (2022) -
Compliance with Standard Precautions among Clinical Nurses: Validity and Reliability of the Italian Version of the Compliance with Standard Precautions Scale (CSPS-It)
por: Donati, Daniele, et al.
Publicado: (2019) -
Autophagy impairment in a mouse model of neuropathic pain
por: Berliocchi, Laura, et al.
Publicado: (2011) -
Computational Mechanistic Insights on the NO Oxidation Reaction Catalyzed by Non-Heme Biomimetic Cr-N-Tetramethylated Cyclam Complexes
por: Marino, Tiziana, et al.
Publicado: (2019) -
Ovothiol Isolated from Sea Urchin Oocytes Induces Autophagy in the Hep-G2 Cell Line
por: Russo, Gian Luigi, et al.
Publicado: (2014)